Brands: Fosrenol · Lanthanum Carbonate
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | unknown | 6 | SUPPLYING |
| Exelan Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Takeda Pharmaceuticals America, Inc. | unknown | 3 | SUPPLYING |
| Lupin Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Prasco Laboratories | unknown | 3 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 3 | SUPPLYING |
| Cipla USA Inc. | unknown | 3 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed stability specifications: Out of specification for hardness test — Recalling firm: Cipla USA, Inc. — Nationwide in the USA
Failed stability specifications: Out of specification for hardness test — Recalling firm: Cipla USA, Inc. — Nationwide in the USA
Pill